Research Network Arizona

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease2 trials
• Macular degeneration2 trials

Phase

• Phase 34 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Recruiting5 trials
• Active, not recruiting1 trial

Lead sponsor

• 4D Molecular Therapeutics2 trials
• Kodiak Sciences Inc2 trials
• Apellis Pharmaceuticals, Inc.1 trial
• Boehringer Ingelheim1 trial

Running trials

• Recruiting

  A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).

  NCT07867080· Phase 3· 4D Molecular Therapeutics· Source

  Contact: 4DMT Patient Advocacy

• Recruiting

  A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

  NCT07553429· Phase 1/2· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

  NCT06990399· Phase 3· Kodiak Sciences Inc· Source

  Contact: Kodiak Sciences Inc

• Recruiting

  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT07064759· Phase 3· 4D Molecular Therapeutics· Source

  Contact: 4DMT Patient Advocacy

• Recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

  NCT06996080· Phase 3· Kodiak Sciences Inc· Source

  Contact: Kodiak Sciences Inc

• Recruiting

  A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

  NCT07215390· Phase 2· Apellis Pharmaceuticals, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic eye disease2 recruiting
• Macular degeneration1 recruiting